See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2024_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 403,802,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 465,000 |
| 3 | remainder_Assets | 30,419,000 |
| 4 | LiabilitiesCurrent | 36,843,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 105,587,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 77,693,548 |
| 9 | ResearchAndDevelopmentExpense | 79,028,273 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 31,073,000 |
| 12 | remainder_NetIncome | -6,878,605 |
| 13 | remainder_ComprehensiveNetIncome | -312,183 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 434,686,000 |
| 1 | Liabilities | 142,430,000 |
| 2 | Expenses | 156,721,821 |
| 3 | Revenues | 31,073,000 |
| 4 | StockholdersEquity | 292,256,000 |
| 5 | NetIncome | -132,527,426 |
| 6 | ComprehensiveNetIncome | -132,683,518 |
| 7 | BaseVar | 386,050,804 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.75 |
| 9 | EconomicCapitalRatio | 2.85 |
Edgar->Model Mapping
Feature Distribution
Change over Time
